Multilateral Relations

EU replaces COVID-19 vaccines export authorisation mechanism with new monitoring tool

Brussels, 26/11/2021 - 12:00, UNIQUE ID: 211129_5
Press releases

EU News 264/2021

The EU will not extend the COVID-19 vaccines export transparency and authorisation mechanism, which expires on 31 December 2021. This means that, as of 1 January 2022, vaccine producers will no longer have to request an authorisation for the export of vaccines outside the EU. Transparency of exports will continue to be ensured through a new monitoring mechanism that will provide the European Commission with timely, company-specific vaccine export data. The Commission will continue to monitor the ongoing epidemiological situation in order to take appropriate measures if necessary.

This decision is part of broader EU efforts to facilitate the widest and fastest production and equitable distribution of COVID-19 vaccines that the world urgently needs:

  • The EU is the biggest global provider of COVID-19 vaccines with over 1.3 billion doses exported so far, more than half of its production.
  • The EU will also donate at least 500 million doses to the most vulnerable countries over the next few months.
  • The EU has committed €1 billion to create manufacturing hubs in different regions in Africa with our African partners and our industrial partners. The aim is to ramp up permanent vaccine production capacity and distribute it better across the world.
  • The EU has been actively engaged in seeking agreement within the World Trade Organization (WTO) of a holistic response to the COVID-19 pandemic so as to facilitate production and export of vaccines and other essential medicines.
Editorial Sections: